Despite a lacklustre start to the year, Novartis seems to have overcome its financial slump, reporting operating profits in Q2 that exceeded analyst expectations. The Swiss drugma ...

Halozyme Therapeutics has signed a global partnership and licence agreement with Incyte to assess additional subcutaneous formulations of INCA033989 in patients with mutCALR-expressing MPNs.

This AI-centric partnership deepens ties between Eli Lilly and Insilico Medicines. Credit: Jiw Ingka / Shutterstock.com. Eli Lilly is joining forces with artificial intelligence (AI)-powered biotech, ...

Novo Nordisk has expanded the use of AI across its R&D, manufacturing and commercial operations. Credit: Jiw Ingka / Shutterstock.com. Novo Nordisk has partnered with tech giant OpenAI to expedite its ...

The JCA process does not have any influence over pricing and Ipsen must still navigate reimbursement access on a country-by-country basis. Credit: HJBC / Shutterstock.com. The first published joint ...

Samsung Biologics is set to acquire PolyPeptide Group through an all-cash public tender offer valued at SFr1.46bn ($1.81bn).

Aptar Pharma has launched a collaborative system-level framework designed to support the development of injectable drug delivery systems.

UK biotech financing recovery was present in the private markets in Q2 2026 as the sector contends with a tough global funding landscape.

The therapies’ availability will offer a route to personalised, mutation-specific approaches for types of rare blood cancers.

Now, her ongoing alliance with a telehealth company may be signifying a broader shift in US healthcare advertising, reflecting a changing of the guard in celebrity endorsements. The 23-time Grand Slam ...

Women’s health companies secured a record $1.55bn in funding in 2025, hinting that investors’ faith is growing in this sector. According to a global women’s health investmen ...

Anthropic launches Claude Science as big tech companies increasingly eye expansion in the wider healthcare and life sciences space.